China says talks to include Paxlovid in state health insurance fail
China's Health Security Administration said on Sunday that talks to include Pfizer's Paxlovid in the latest drug list for basic state health insurance did not succeed.
The talks fell through was due to Pfizer's high quotation for Paxlovid. Pfizer did not immeditately respond to a request to comment.
ALSO READ
-
U.S. Treasury Pushes China for Hormuz Diplomacy
-
Broadcast Battle: FIFA Struggles to Secure World Cup Rights in India and China
-
U.S. Treasury Urges China to Influence Iran for Strait of Hormuz Resolution
-
Broadcast Rights Dispute May Leave Millions Without World Cup Viewing in India and China
-
Broadcasting Stalemate Threatens World Cup Viewership in India and China
Google News